||EPS - Basic
||Market Cap (m)
Aviva Share Discussion Threads
Showing 22451 to 22474 of 22475 messages
|Time for a cheeky little short|
|Like watching paint dry|
|H1 results on the 4th August. Not too long to wait.|
|You can tell that is from TMF as they write in a very staightlaced style. They had been pumping AV and Barclays for a long time - I don't rate their stock picking at all.|
|speedsgh, All I can say is, thank you to citywire up 4% plus so far today, next stop £4.00 on the chart, lets hope we have another sell from the so called experts !!!|
|Better insurers than Aviva out there - HTTP://citywire.co.uk/money/the-expert-view-unilever-aviva-and-aberdeen/a928944?ref=citywire-money-picture-galleries-list#i=4
The sell-off of insurers post-referendum may be overdone, there are still better options out there than Aviva (AV).
Shore Capital analyst Eamonn Flanagan reiterated his ‘sell’ recommendation and does not have a target price on the stock. The shares fell 4.5% to 358.6p yesterday.
Ahead of a capital markets day Flanagan expected Aviva management to flag the strength of the company’s balance sheet.
‘We leave our 2016 and 2017 earnings per share unchanged for now, at 51.7p and 56p respectively, with forecast dividends of 24p and 28p respectively,’ he said. ‘With forward yields of c.6.4% and c7.5% respectively, the stock has undoubted income attractions.
‘However, to us, the 8.3% rising to 8.9% yields offers by Legal and General remain more appealing and hence, on a relative basis, we reiterate our “sell” recommendation on Aviva.’
He added: ‘Nevertheless, we view the post-Brexit sell-off across the quoted life companies as materially overdone with all of the players offering decent upside potential on an absolute basis once the dust settles and some sense of order emerges.’|
|I'm a buyer too. Also L&G.|
|im a buyer...all in my ISA and I look forward to nice dividends for years to come whilst interest rates remain next to non existent|
|Or the brave buy a few...|
|Hence it not moving todayAt first glance, general insurance giant Aviva (LSE: AV) may appear too good to be true to stock chasers. With earnings expected to double in 2016, the FTSE 100 (INDEXFTSE: UKX) stock currently trades on a P/E rating of 8.7 times, well below the benchmark of 10 times that's considered exceptionally cheap.And City forecasts of a 23.6p-per-share dividend yields a staggering 5.8%, a figure that mashes the big-cap average of 3.5% by some distance.But the result of last month's Brexit decision has forced me to reconsider my previously-bullish view of the firm. The full impact of the referendum is likely to take years to be felt. But the result on Aviva's asset management arm is already being seen -- the company was one of several financial firms to halt redemptions at its property fund last week.And while Aviva's extensive international exposure should take the sting out of weakness at its insurance division, the company still sources a sizeable chunk of its profits here in the UK, leaving it in severe peril should a recession occur. I reckon investors should give Aviva short shrift for the time being.|
|Not sure why insurers have fallen so far and failed to recover given overall market level remains healthy. Have prospects for Aviva fallen that far? What am I missing?|
its the oxman
|There is no such thing as specific reasoning in these markets...for a start the chart is not looking good....No Advice Intended....you do what suits you...|
|Retested again? What, from 2011, 2011 and 2013?
Surely ancient history with the new CEO Mark Wilson (from 2013) and new focused business profile. Do you have a specific reasoning?|
|Think that 300p could get retested again over the coming weeks...|
|Even after positive news this share can't stay up.... Frustrating bought in at 3.62|
|Sounds reasonable Carl. Good luck.|
|Shorters targeted AV recently - more greed than panic there - some of them are very good at what they do...but their actions cause the regular folk to panic and of course probably hit a few unsuspecting people's limit orders in the process...their released stock is then picked up on the cheap as the shorters close, profit made...
I topped up here and in Glencore...if I make short term losses, I will lose little sleep. These are in my ISA and I expect many years of profit and dividends.|
|I just don't get why the panic sellers are here, its very strange, it must be robot computers - can't be humans.|
|An incredible bargain. Not quite as good as brexit Friday but should pay for my trip to LyonPanic sellers.... aaaaarrrggghhhhh!|
|Agree Dr. Biotech...just shows how negative the market can get with the recent hiccup on uncertainties over property values etc. However, customers need insurance and their pensions managed so life trudges on albeit at an uncertain pace. Like LGEN and a few others in the sector the management teams appear very strong and astute so I think that the market will start to regain some confidence over coming months. It would be probably helped if Mrs. May is given the keys to No.10 asap, and she will be seen as a much needed steady hand. Good luck here although a bit more invested in lgen for my sins at present. Finally have to say that the AV. company outline given this morning was quite reassuring in most respects but may take a little time to sink in...the analysts always trying to cover their backxxxx as usual, and therefore tend to over-react.|
|I hold sl. And watch AV. Both of these are a solid long term hold, market is just scaring folks out for cheap stock. Both have great divis and will ride this out.Be lucky to all.|
|Whatever they said this morning it didn't do a lot for sentiment. Think we will be laid low here for sometime until it becomes clearer what Brexit actually means.|